Novavax, Inc. (NVAX)

Last Closing Price: 6.73 (2025-05-16)

Income from Continuous Operations (Quarterly)

Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.

Novavax, Inc. (NVAX) had Income from Continuous Operations of $518.65M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$666.65M
$518.65M
$14.12M
$652.54M
$151.14M
$515.51M
$4.33M
$519.85M
$519.85M
$518.65M
Income from Continuous Operations
$518.65M
$518.65M
$518.65M
$515.51M
$523.85M
161.05M
177.62M
$3.22
$2.93
Balance Sheet Financials
$868.03M
$133.54M
$424.96M
$1.29B
$422.17M
$223.18M
$946.47M
$1.37B
$-75.64M
$-187.67M
$-75.64M
161.96M
Cash Flow Statement Financials
$-185.50M
$-73.32M
$-7.06M
$545.29M
$278.48M
$-266.81M
$10.29M
--
--
Fundamental Metrics & Ratios
2.06
--
--
1.51
-3.02
97.88%
77.33%
77.33%
--
77.98%
77.80%
$-186.72M
--
--
--
0.52
1.38
14.98
6.01
-685.65%
-276.36%
40.11%
351.53%
$-0.47
$-1.05
$-1.04